Document Detail

Eclampsia : before and after magnesium sulphate.
MedLine Citation:
PMID:  16751814     Owner:  NLM     Status:  MEDLINE    
This study was done to see the incidence and impact of changes in the intervention strategy for the management of eclampsia in a maternity hospital on maternal and perinatal outcome. Analysis of case records of all eclampsia cases over two different study periods designated as study period A (April, 1994 to Oct, 1996) and study period B (April, 2000 to April, 2001) were done. Total number of eclampsia cases who received intervention over two different study period (46 in study period A and 47 in study period B) were comparable despite the difference in the duration of study period. During study period A, diazepam was used as anticonvulsant, whereas magnesium sulphate was used to control fits during study period B. Incidence of eclampsia has markedly increased in this hospital (0.12% vs 0.29%). Epidemiology and clinical profile of eclamptic patients do not show remarkable change. There was no maternal death in study period B (April, 2000 to April, 2001) whereas there was one maternal death in the study period A (April, 1994 to October, 1996). Marked improvement was noticed in terms of recurrence of fit (19.13% vs 73.91%) with change in the intervention strategy. Perinatal deaths were fewer in study period B (20% vs 33%). Overall, it seems that care of eclamptic patients and use of magnesium sulphate as anticonvulsant has resulted in positive impact on maternal outcome.
P Chaudhary
Related Documents :
15097234 - Hypertension-related gene polymorphisms in pre-eclampsia, eclampsia and gestational hyp...
7837214 - Cigarette smoking in pregnancy and risk of pre-eclampsia.
15282004 - Study of peripheral circulation in non-pregnant, pregnant and pre-eclamptic women using...
1615984 - Eclampsia. vii. pregnancy outcome after eclampsia and long-term prognosis.
20087924 - Association of first-trimester low papp-a levels with preterm birth.
7136644 - Multiple congenital abnormalities in a newborn boy associated with maternal use of flup...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  JNMA; journal of the Nepal Medical Association     Volume:  44     ISSN:  0028-2715     ISO Abbreviation:  JNMA J Nepal Med Assoc     Publication Date:    2005 Oct-Dec
Date Detail:
Created Date:  2006-06-05     Completed Date:  2008-05-20     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0045233     Medline TA:  JNMA J Nepal Med Assoc     Country:  Nepal    
Other Details:
Languages:  eng     Pagination:  124-8     Citation Subset:  IM    
Maternity Hospital, Thapathali, Kathmandu, Nepal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticonvulsants / therapeutic use*
Diazepam / therapeutic use*
Drug Therapy, Combination
Eclampsia / drug therapy*
Hospitals, Maternity / statistics & numerical data
Magnesium Sulfate / therapeutic use*
Nepal / epidemiology
Nifedipine / therapeutic use
Premature Birth / epidemiology
Retrospective Studies
Stillbirth / epidemiology
Tocolytic Agents / therapeutic use
Treatment Outcome
Reg. No./Substance:
0/Anticonvulsants; 0/Tocolytic Agents; 21829-25-4/Nifedipine; 439-14-5/Diazepam; 7487-88-9/Magnesium Sulfate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Trend of blood group distribution among the Jirels of Nepal.
Next Document:  Medication counseling center in a teaching hospital.